Structure-activity studies of verapamil analogs that modulate transport of leukotriene C4 and reduced glutathione by multidrug resistance protein MRP1

Biochemical and Biophysical Research Communications

Volumn 275, Issue 3, 2000, Pages 795-803

  Loe, Douglas W ^a   Oleschuk, Curtis J ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

ATP binding cassette; Glutathione; Leukotriene C4; MRP; Multidrug resistance protein; Transport; Verapamil analog

Indexed keywords

GLUTATHIONE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN MRP1; N (3,4 DIMETHOXYPHENETHYL) N METHYL 2 (2 NAPHTHYL) 1,3 DITHIANE 2 PROPYLAMINE; RO 10 6852; RO 11 1766; RO 11 1768; RO 11 1769; RO 11 2751; RO 11 3662; RO 11 4298; RO 44 5911; RO 44 5912; UNCLASSIFIED DRUG; VERAPAMIL; VERAPAMIL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

EID: 0034618582     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3384     Document Type: Article

References (41)

1. Structural, mechanistic and clinical aspects of MRP1
2. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood
3. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
4. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
5. 2-terminus
6. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
7. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
8. The P-glycoprotein efflux pump: How does it transport drugs?
9. 4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport
10. 1 and its glutathione conjugates by the product of the MRP gene
11. Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: Evidence for co-transport with reduced glutathione
12. 4 (LTC4) in isolated plasma membrane vesicles
13. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
14. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2
15. ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump
16. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione
17. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein
18. Effect of calcium antagonists on the chemosensitivity of two multidrug resistant human tumour cell lines which do not overexpress P-glycoprotein
19. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein
20. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
21. Mechanisms of multidrug resistance in HL60 cells: Analysis of resistance associated membrane proteins and levels of mdr gene expression
22. ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells
23. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
24. The effect of glutathione on the ATPase activity of MRP1 in its natural membranes
25. Verapamil stimulates glutathione transport by the multidrug resistance protein 1 (MRP1)
26. Multidrug resistance mediated by the Multidrug Resistance Protein (MRP) gene
27. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation
28. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells
29. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells
30. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933
31. Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines
32. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs
33. Reversal of multidrug resistance by verapamil analogues
34. Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil
35. The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer
36. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin
37. Structural dependence of the allosteric interaction of semi-rigid verapamil analogues with diihydropyridine-binding in kitten heart
38. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro
39. The dithiane Ro44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo
40. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
41. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells